Sign In
Buy GENE
$0.765
+0 (+0%)
At Close: Jan 15, 2025
Genetic testing firm investigated over hack
05:49pm, Monday, 10'th Jun 2024
A joint investigation into a data breach at DNA testing company has been launched by UK and Canadian watchdogs.
23andMe Launches New Genetic Report on Bipolar Disorder
07:00am, Wednesday, 05'th Jun 2024
Provides 23andMe+ Premium members with insight into their likelihood of developing the serious mental health illness based on thousands of genetic variants Provides 23andMe+ Premium members with insig
Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)
10:12pm, Sunday, 19'th May 2024
PROTALIX BIOTHERAPEUTICS C O R P O R A T E P R E S E N T A T I O N M a y 2 0 2 4 Disclaimers Third-Party Information This presentation also contains estimates and other data made by independent partie
Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)
10:12pm, Sunday, 19'th May 2024
PROTALIX BIOTHERAPEUTICS C O R P O R A T E P R E S E N T A T I O N M a y 2 0 2 4 Disclaimers Third-Party Information This presentation also contains estimates and other data made by independent partie
SJMC's significant efforts in alleviating nursing shortages, enhancing workflows and its strong market-leading position, both locally and globally resulted in high patient retention and strong referra
Appendix 4C & Quarterly Business Update – March 2024
08:00am, Tuesday, 30'th Apr 2024
MELBOURNE, Australia, April 30, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in he
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
03:00pm, Monday, 22'nd Apr 2024
MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driv
Genetic Technologies Announces $2 Million Registered Direct Offering
12:17pm, Thursday, 18'th Apr 2024
MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
09:00am, Friday, 12'th Apr 2024
ORLANDO, FL / ACCESSWIRE / April 12, 2024 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks, Big Money�
Genetic Technologies' Digital Strategy Ignites Significant Traction in US Market
08:05am, Tuesday, 02'nd Apr 2024
MELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness an
GTG to launch U.S. Customer Digital Media Sales Campaign
08:00am, Wednesday, 28'th Feb 2024
MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targete
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
08:31am, Friday, 09'th Feb 2024
Testing offers CBR families the opportunity to proactively seek additional information about their child's health TRUMBULL, Conn. and EL MONTE, Calif.
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
08:00am, Friday, 05'th Jan 2024
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests in health, wellness, and serious disease, adv
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
09:00am, Friday, 29'th Dec 2023
ORLANDO, FL / ACCESSWIRE / December 29, 2023 / RedChip Companies will air interviews with Genetic Technologies Limited (NASDAQ:GENE) and BioVie, Inc. (NASDAQ:BIVI) on The RedChip Small Stocks Big Mone
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
08:00am, Tuesday, 12'th Dec 2023
MELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and
